{"id":14275,"date":"2026-06-25T09:21:10","date_gmt":"2026-06-25T09:21:10","guid":{"rendered":"https:\/\/glabridinchina.com\/?p=14275"},"modified":"2026-06-25T09:25:43","modified_gmt":"2026-06-25T09:25:43","slug":"eye-area-brightening-addressing-dark-circles-with-glabridin","status":"publish","type":"post","link":"https:\/\/glabridinchina.com\/fr\/eye-area-brightening-addressing-dark-circles-with-glabridin\/","title":{"rendered":"Eye Area Brightening: Addressing Dark Circles with Glabridin"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"14275\" class=\"elementor elementor-14275\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-cc9cd90 e-flex e-con-boxed e-con e-parent\" data-id=\"cc9cd90\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d07bcf6 elementor-widget elementor-widget-html\" data-id=\"d07bcf6\" data-element_type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t  <script type=\"application\/ld+json\">{\n    \"@context\": \"https:\\\/\\\/schema.org\",\n    \"@type\": \"Article\",\n    \"mainEntityOfPage\": {\n        \"@type\": \"WebPage\",\n        \"@id\": \"https:\\\/\\\/glabridinchina.com\\\/eye-area-brightening-addressing-dark-circles-with-glabridin\\\/\"\n    },\n    \"headline\": \"Eye Area Brightening: Addressing Dark Circles with Glabridin\",\n    \"about\": {\n        \"@type\": \"ChemicalSubstance\",\n        \"name\": \"Glabridin\",\n        \"alternateName\": \"\\u5149\\u7518\\u8349\\u5b9a\"\n    },\n    \"publisher\": {\n        \"@type\": \"Organization\",\n        \"name\": \"Huatai Bio-Fine Chemical\",\n        \"url\": \"https:\\\/\\\/glabridinchina.com\"\n    },\n    \"author\": {\n        \"@type\": \"Organization\",\n        \"name\": \"Huatai Bio-Fine Chemical Technical Team\"\n    },\n    \"datePublished\": \"2026\",\n    \"description\": \"A technical guide to formulating dark circle treatments using glabridin, covering the three distinct causes of periorbital darkness, the rationale for anti-inflammatory brightening in the eye area, active system design, and formulation considerations for the periorbital zone.\"\n}<\/script>\n\n  <link rel=\"preconnect\" href=\"https:\/\/fonts.googleapis.com\">\n  <link rel=\"preconnect\" href=\"https:\/\/fonts.gstatic.com\" crossorigin>\n  <link href=\"https:\/\/fonts.googleapis.com\/css2?family=Inter:wght@300;400;500;600;700&family=Merriweather:ital,wght@0,400;0,700;1,400&display=swap\" rel=\"stylesheet\">\n\n  <style>\n    :root {\n      --color-bg:           #f9f9f7;\n      --color-surface:      #ffffff;\n      --color-border:       #e5e2d9;\n      --color-text:         #1c1c1a;\n      --color-text-muted:   #6a6760;\n      --color-accent:       #2d5a3d;\n      --color-accent-light: #edf4ef;\n      --color-accent-mid:   #4a7c5f;\n      --color-warn:         #A0522D;\n      --color-warn-light:   #fef0e6;\n      --color-data-bg:      #f3f1ed;\n      --font-heading:       'Merriweather', Georgia, 'Times New Roman', serif;\n      --font-body:          'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', Helvetica, Arial, sans-serif;\n      --max-width:          800px;\n      --radius:             6px;\n    }\n\n    *, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }\n    html { scroll-behavior: smooth; }\n\n    body {\n      font-family: var(--font-body);\n      font-size: 16px;\n      line-height: 1.8;\n      color: var(--color-text);\n      background: var(--color-bg);\n      -webkit-font-smoothing: antialiased;\n    }\n\n    .page-wrap { max-width: 100%; margin: 0 auto; padding: 0 24px 80px; }\n\n    .site-header {\n      border-bottom: 1px solid var(--color-border);\n      padding: 16px 24px;\n      display: flex; align-items: center; gap: 10px;\n    }\n    .site-header .brand { font-size: 14px; font-weight: 600; color: var(--color-accent); text-decoration: none; }\n    .site-header .sep { color: var(--color-border); }\n    .site-header .section-label { font-size: 13px; color: var(--color-text-muted); }\n\n    .article-header { padding: 48px 0 32px; border-bottom: 1px solid var(--color-border); margin-bottom: 40px; }\n    .tag-row { display: flex; gap: 8px; margin-bottom: 16px; flex-wrap: wrap; }\n    .tag {\n      font-size: 11px; font-weight: 600; letter-spacing: 0.07em;\n      text-transform: uppercase; padding: 3px 9px; border-radius: 3px;\n      background: var(--color-accent-light); color: var(--color-accent);\n    }\n    .tag.secondary { background: var(--color-data-bg); color: var(--color-text-muted); }\n\n    h1 {\n      font-family: var(--font-heading);\n      font-size: clamp(24px, 3.5vw, 34px);\n      font-weight: 700; line-height: 1.25;\n      color: var(--color-text); margin-bottom: 16px; letter-spacing: -0.01em;\n    }\n    .article-intro { font-size: 17px; line-height: 1.7; color: var(--color-text-muted); font-weight: 300; max-width: 100%; }\n    .byline { margin-top: 18px; font-size: 13px; color: var(--color-text-muted); display: flex; align-items: center; gap: 12px; flex-wrap: wrap; }\n    .byline strong { color: var(--color-text); font-weight: 600; }\n\n    .article-body h2 {\n      font-family: var(--font-heading); font-size: 20px; font-weight: 700;\n      color: var(--color-text); margin: 48px 0 14px; padding-bottom: 10px;\n      border-bottom: 2px solid var(--color-accent-light); letter-spacing: -0.01em;\n    }\n    .article-body h3 { font-family: var(--font-heading); font-size: 17px; font-weight: 700; color: var(--color-text); margin: 32px 0 12px; }\n    .article-body p { margin-bottom: 16px; }\n    .article-body ul { margin: 10px 0 18px; padding-left: 0; list-style: none; }\n    .article-body ul li { padding: 4px 0 4px 20px; position: relative; }\n    .article-body ul li::before { content: '\u2014'; position: absolute; left: 0; color: var(--color-accent-mid); font-weight: 600; }\n    .article-body strong { font-weight: 600; }\n    .article-body em { font-style: italic; }\n\n    .table-wrap { overflow-x: auto; margin: 20px 0 24px; border-radius: var(--radius); border: 1px solid var(--color-border); }\n    table { width: 100%; border-collapse: collapse; font-size: 14.5px; }\n    thead th {\n      background: var(--color-data-bg); font-weight: 600; font-size: 11px;\n      letter-spacing: 0.05em; text-transform: uppercase; color: var(--color-text-muted);\n      padding: 10px 14px; text-align: left; border-bottom: 1px solid var(--color-border);\n    }\n    tbody td { padding: 9px 14px; border-bottom: 1px solid var(--color-border); vertical-align: top; line-height: 1.55; }\n    tbody tr:last-child td { border-bottom: none; }\n    tbody tr:hover { background: #fafaf6; }\n    td strong { color: var(--color-accent); }\n\n    .callout {\n      border-left: 3px solid var(--color-accent); background: var(--color-accent-light);\n      padding: 14px 18px; border-radius: 0 var(--radius) var(--radius) 0;\n      margin: 20px 0; font-size: 15px; line-height: 1.65;\n    }\n    .callout.warning { border-left-color: var(--color-warn); background: var(--color-warn-light); }\n    .callout p { margin-bottom: 0; }\n    .callout p + p { margin-top: 8px; }\n\n    .cause-card {\n      background: var(--color-surface);\n      border: 1px solid var(--color-border);\n      border-radius: var(--radius);\n      padding: 18px 20px;\n      margin: 16px 0;\n    }\n    .cause-card-title {\n      font-family: var(--font-heading);\n      font-size: 15px; font-weight: 700;\n      color: var(--color-text); margin-bottom: 8px;\n    }\n    .cause-card p { margin-bottom: 8px; font-size: 15px; }\n    .cause-card p:last-child { margin-bottom: 0; }\n\n    .related-section { margin-top: 52px; padding-top: 28px; border-top: 1px solid var(--color-border); }\n    .related-section h2 {\n      font-family: var(--font-body); font-size: 12px; font-weight: 700;\n      margin-bottom: 14px; color: var(--color-text-muted); border: none; padding: 0;\n      text-transform: uppercase; letter-spacing: 0.07em;\n    }\n    .related-links { display: grid; gap: 8px; }\n    .related-link {\n      display: flex; align-items: center; gap: 12px; padding: 12px 14px;\n      background: var(--color-surface); border: 1px solid var(--color-border);\n      border-radius: var(--radius); text-decoration: none; color: var(--color-text);\n      font-size: 14px; transition: border-color 0.15s, background 0.15s;\n    }\n    .related-link:hover { border-color: var(--color-accent); background: var(--color-accent-light); }\n    .related-link-arrow { color: var(--color-accent); font-size: 16px; flex-shrink: 0; margin-left: auto; }\n\n    .cta-box {\n      margin-top: 36px; background: var(--color-accent); border-radius: var(--radius);\n      padding: 24px 28px; display: flex; align-items: center;\n      justify-content: space-between; gap: 20px; flex-wrap: wrap;\n    }\n    .cta-box-text { color: rgba(255,255,255,0.85); font-size: 14px; }\n    .cta-box-text strong { color: #fff; display: block; font-size: 16px; margin-bottom: 3px; font-family: var(--font-heading); }\n    .cta-btn {\n      background: #fff; color: var(--color-accent); text-decoration: none;\n      font-weight: 700; font-size: 13px; padding: 9px 20px; border-radius: 4px;\n      white-space: nowrap; flex-shrink: 0;\n    }\n\n    .references { margin-top: 44px; padding-top: 24px; border-top: 1px solid var(--color-border); }\n    .references h2 {\n      font-family: var(--font-body); font-size: 12px; font-weight: 700;\n      margin-bottom: 12px; color: var(--color-text-muted); border: none; padding: 0;\n      text-transform: uppercase; letter-spacing: 0.07em;\n    }\n    .references ol { padding-left: 18px; }\n    .references li { font-size: 13px; color: var(--color-text-muted); line-height: 1.6; margin-bottom: 7px; }\n\n    .article-footer { margin-top: 36px; padding-top: 18px; border-top: 1px solid var(--color-border); font-size: 12px; color: var(--color-text-muted); line-height: 1.6; }\n  <\/style>\n<\/head>\n<body>\n\n  <div class=\"page-wrap\">\n\n    <header class=\"article-header\">\n      <div class=\"tag-row\">\n        <span class=\"tag\">Application<\/span>\n        <span class=\"tag secondary\">Glabridine<\/span>\n        <span class=\"tag secondary\">Zone des Yeux<\/span>\n        <span class=\"tag secondary\">Cernes<\/span>\n      <\/div>\n      <p class=\"article-intro\">Les cernes comptent parmi les pr\u00e9occupations esth\u00e9tiques les plus courantes en mati\u00e8re de soins de la peau \u2014 et parmi les plus fr\u00e9quemment mal formul\u00e9s. L'erreur la plus courante consiste \u00e0 appliquer une approche \u00e9claircissante g\u00e9n\u00e9rale \u00e0 un probl\u00e8me qui, dans la plupart des cas, n'est pas uniquement d\u00fb \u00e0 la production de m\u00e9lanine. Un \u00e9claircissement efficace de la zone des yeux n\u00e9cessite d'identifier laquelle des trois causes principales est dominante \u2014 vasculaire, structurelle ou pigmentaire \u2014 et de s\u00e9lectionner des actifs qui traitent le m\u00e9canisme sous-jacent.<\/p>\n      <div class=\"byline\">\n        <span><strong>Huatai Bio-Fine Chemical<\/strong> \u2014 fabricant d'actifs cosm\u00e9tiques de haute puret\u00e9 depuis 2008<\/span>\n        <span style=\"color:var(--color-border)\">\u00b7<\/span>\n        <span>Publi\u00e9 2026<\/span>\n      <\/div>\n    <\/header>\n\n    <article class=\"article-body\">\n\n      <p>Les cernes comptent parmi les pr\u00e9occupations esth\u00e9tiques les plus courantes en mati\u00e8re de soins de la peau \u2014 et parmi les plus fr\u00e9quemment mal formul\u00e9s. L'erreur la plus courante consiste \u00e0 appliquer une approche \u00e9claircissante g\u00e9n\u00e9rale \u00e0 un probl\u00e8me qui, dans la plupart des cas, n'est pas uniquement d\u00fb \u00e0 la production de m\u00e9lanine. Un \u00e9claircissement efficace de la zone des yeux n\u00e9cessite d'identifier laquelle des trois causes principales est dominante \u2014 vasculaire, structurelle ou pigmentaire \u2014 et de s\u00e9lectionner des actifs qui traitent le m\u00e9canisme sous-jacent.<\/p>\n\n      <p>La glabridine est pertinente pour les trois voies des cernes \u2014 mais avec des niveaux de contribution diff\u00e9rents. Comprendre la distinction d\u00e9termine si la glabridine doit \u00eatre l'actif principal, un co-actif ou un ingr\u00e9dient de soutien dans une formulation oculaire donn\u00e9e.<\/p>\n\n      <h2>Les Trois Causes des Cernes<\/h2>\n\n      <div class=\"cause-card\">\n        <div class=\"cause-card-title\">Cause 1 \u2014 Vasculaire (Obscurit\u00e9 Bleu-Rouge)<\/div>\n        <p>La peau p\u00e9riorbitaire est exceptionnellement fine \u2014 parmi les plus fines du visage. Les vaisseaux sanguins superficiels sous-jacents deviennent visibles \u00e0 travers la peau, se pr\u00e9sentant comme une d\u00e9coloration bleue, rouge ou violac\u00e9e. Cette apparence est principalement associ\u00e9e \u00e0 la visibilit\u00e9 vasculaire, souvent influenc\u00e9e par le ralentissement microcirculatoire et la dilatation des vaisseaux.<\/p>\n        <p>Les cernes vasculaires sont g\u00e9n\u00e9ralement plus prononc\u00e9s apr\u00e8s un manque de sommeil, une d\u00e9shydratation ou de la fatigue, et ils ont une teinte bleu-rouge plut\u00f4t qu'un ton brun.<\/p>\n        <p><strong>Les actifs \u00e9claircissants ne sont pas l'intervention principale ici.<\/strong> La caf\u00e9ine (vasoconstrictrice et aide \u00e0 r\u00e9duire les poches), le dipeptide-2 (soutient l'\u00e9quilibre hydrique) et les d\u00e9riv\u00e9s de la vitamine K (soutiennent la r\u00e9cup\u00e9ration des d\u00e9colorations li\u00e9es au sang) sont plus pertinents pour traiter les pr\u00e9occupations vasculaires.<\/p>\n      <\/div>\n\n      <div class=\"cause-card\">\n        <div class=\"cause-card-title\">Cause 2 \u2014 Structurelle \/ Ombrage<\/div>\n        <p>La perte de volume dans la zone p\u00e9riorbitaire \u2014 atrophie du coussinet adipeux, approfondissement du sillon lacrymal \u2014 cr\u00e9e un effet d'ombre qui se manifeste par une obscurit\u00e9. Il s'agit d'un probl\u00e8me structurel tridimensionnel, et non d'un probl\u00e8me de pigmentation.<\/p>\n        <p><strong>Les actifs \u00e9claircissants topiques ne peuvent pas traiter directement les causes structurelles.<\/strong> Les peptides soutenant le collag\u00e8ne et l'\u00e9lastine (ac\u00e9tyl t\u00e9trapeptide-5, palmitoyl tripeptide-1) et les actifs filmog\u00e8nes qui am\u00e9liorent l'apparence des irr\u00e9gularit\u00e9s du contour peuvent r\u00e9duire l'apparence des ombres sous les yeux.<\/p>\n      <\/div>\n\n      <div class=\"cause-card\">\n        <div class=\"cause-card-title\">Cause 3 \u2014 Pigmentation (Obscurit\u00e9 brune)<\/div>\n        <p>L'hyperpigmentation p\u00e9riorbitaire vraie \u2014 d\u00e9coloration brune li\u00e9e \u00e0 la m\u00e9lanine dans l'\u00e9piderme et le derme \u2014 est la cible principale des actifs \u00e9claircissants. Elle est plus fr\u00e9quente chez :<\/p>\n        <ul>\n          <li>Les types de peau Fitzpatrick III-VI, o\u00f9 la m\u00e9lanogen\u00e8se est plus sujette \u00e0 la pigmentation<\/li>\n          <li>Les cas post-inflammatoires (dermatite de contact allergique due aux produits pour les yeux, frottement chronique)<\/li>\n          <li>La zone p\u00e9riorbitaire expos\u00e9e aux UV chez les personnes ayant une tendance \u00e0 l'hyperpigmentation<\/li>\n        <\/ul>\n        <p>Les cernes brun\u00e2tres qui persistent ind\u00e9pendamment du sommeil ou de l'hydratation, et qui s'aggravent avec l'exposition au soleil, sont principalement dus \u00e0 la pigmentation.<\/p>\n      <\/div>\n\n      <h2>Pourquoi la glabridine convient-elle \u00e0 la pigmentation p\u00e9riorbitaire ?<\/h2>\n\n      <h3>Le m\u00e9canisme anti-inflammatoire cible la voie principale de l'hyperpigmentation post-inflammatoire (PIH)<\/h3>\n\n      <p>La PIH p\u00e9riorbitaire \u2014 due aux allerg\u00e8nes, aux frictions ou aux traumatismes mineurs r\u00e9p\u00e9t\u00e9s dus au frottement des yeux \u2014 suit les voies de la m\u00e9lanogen\u00e8se inflammatoire impliquant la signalisation COX\/PGE\u2082, similaire \u00e0 la PIH ailleurs sur le visage. L'activit\u00e9 inhibitrice de la COX de la glabridine aide \u00e0 moduler ce m\u00e9canisme, pas seulement le sympt\u00f4me.<\/p>\n\n      <p>Chez les personnes ayant des ant\u00e9c\u00e9dents de r\u00e9actions p\u00e9riorbitaires allergiques (dermatite de contact cosm\u00e9tique, sensibilit\u00e9 aux gouttes oculaires), l'origine inflammatoire de leurs cernes est \u00e9troitement associ\u00e9e aux m\u00e9canismes que la glabridine aide \u00e0 moduler.<\/p>\n\n      <h3>Profil de s\u00e9curit\u00e9 \u2014 Critique pour la zone p\u00e9riorbitaire<\/h3>\n\n      <p>La zone p\u00e9riorbitaire est la zone la plus sensible du visage. La peau plus fine et plus perm\u00e9able signifie que les actifs irritants ou sensibilisants peuvent g\u00e9n\u00e9rer des r\u00e9actions ind\u00e9sirables plus prononc\u00e9es chez certains individus. Le m\u00eame test de provocation humain ferm\u00e9 par des tiers qui a soutenu la s\u00e9curit\u00e9 cutan\u00e9e de la glabridine (30 sujets, aucune r\u00e9action ind\u00e9sirable observ\u00e9e, Rapport n\u00b0 GZA01-23080632-JC-01) soutient sa tol\u00e9rabilit\u00e9 dans les conditions test\u00e9es. La glabridine aux concentrations recommand\u00e9es est g\u00e9n\u00e9ralement bien tol\u00e9r\u00e9e dans des conditions d'utilisation standardis\u00e9es.<\/p>\n\n      <p>En revanche, des actifs tels que l'acide kojique (potentiel de sensibilisation rapport\u00e9), l'acide L-ascorbique \u00e0 haute dose (pH bas et potentiel d'irritation en cas de barri\u00e8re cutan\u00e9e compromise) ou les r\u00e9tino\u00efdes (potentiel d'irritation sur la peau sensible du p\u00e9riorbitaire) pr\u00e9sentent des risques \u00e9lev\u00e9s dans la zone oculaire.<\/p>\n\n      <h3>Efficacit\u00e9 \u00e0 faible concentration<\/h3>\n\n      <p>L'\u00e9tude clinique humaine d\u00e9montrant une r\u00e9duction de 16,8 % du MI \u00e0 une concentration active de 0,03 % fournit une r\u00e9f\u00e9rence pertinente pour le contr\u00f4le topique de la pigmentation, y compris pour la formulation de la zone oculaire. Un \u00e9claircissement efficace peut \u00eatre obtenu \u00e0 des concentrations qui ne soumettent pas la peau fine et sensible du p\u00e9riorbitaire \u00e0 un stress excessif. Un niveau d'utilisation cible de 0,1 \u00e0 0,2 % d'actif offre une marge pratique au-dessus de la concentration \u00e9tudi\u00e9e, sans n\u00e9cessiter de doses plus \u00e9lev\u00e9es qui pourraient augmenter les consid\u00e9rations de tol\u00e9rabilit\u00e9.<\/p>\n\n      <h2>Niveau d&#039;utilisation recommand\u00e9<\/h2>\n\n      <p><strong>0,1\u20130,2 % d'actif<\/strong> dans la formulation finie.<\/p>\n\n      <p>Cette gamme offre un potentiel d'inhibition de la tyrosinase et une activit\u00e9 anti-inflammatoire tout en restant coh\u00e9rente avec les observations de tol\u00e9rabilit\u00e9 issues des tests de provocation. \u00c0 0,03 %, l'\u00e9claircissement clinique \u00e9tait statistiquement significatif d\u00e8s la semaine 1 \u2014 0,1\u20130,2 % d'actif peut offrir un potentiel d'efficacit\u00e9 accru dans un d\u00e9lai comparable.<\/p>\n\n      <h2>Syst\u00e8me d'actifs compl\u00e9mentaires pour la zone oculaire<\/h2>\n\n      <h3>Pour les cernes primaires dus \u00e0 la pigmentation<\/h3>\n\n      <div class=\"table-wrap\">\n        <table>\n          <thead>\n            <tr>\n              <th>Actif<\/th>\n              <th>M\u00e9canisme<\/th>\n              <th>Rationnel pour la zone oculaire<\/th>\n            <\/tr>\n          <\/thead>\n          <tbody>\n            <tr>\n              <td><strong>Glabridine<\/strong> (primaire)<\/td>\n              <td>Inhibition de la tyrosinase + anti-inflammatoire COX<\/td>\n              <td>Contribue \u00e0 la r\u00e9gulation de la production de m\u00e9lanine et aux voies inflammatoires li\u00e9es aux PIH<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Niacinamide<\/strong><\/td>\n              <td>Inhibition du transfert des m\u00e9lanosomes<\/td>\n              <td>Downstream modulation; well-tolerated in periorbital zone<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Caf\u00e9ine<\/strong><\/td>\n              <td>Vasoconstrictive; helps reduce puffiness<\/td>\n              <td>Co-addresses vascular component that often accompanies pigmentation dark circles<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Dipeptide-2<\/strong><\/td>\n              <td>Lymphatic support; anti-edema effect<\/td>\n              <td>Reduces puffiness that contributes to shadow appearance<\/td>\n            <\/tr>\n          <\/tbody>\n        <\/table>\n      <\/div>\n\n      <h3>For Mixed Etiology Dark Circles (Pigmentation + Vascular)<\/h3>\n\n      <div class=\"table-wrap\">\n        <table>\n          <thead>\n            <tr>\n              <th>Actif<\/th>\n              <th>M\u00e9canisme<\/th>\n            <\/tr>\n          <\/thead>\n          <tbody>\n            <tr>\n              <td><strong>Glabridine<\/strong> (0.1\u20130.2% active)<\/td>\n              <td>Pigmentation: tyrosinase inhibition + COX anti-inflammatory<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Caf\u00e9ine<\/strong> (1\u20133%)<\/td>\n              <td>Vascular: vasoconstrictive; reduces microcirculatory pooling appearance<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Dipeptide-2<\/strong> (2\u20134 ppm typical)<\/td>\n              <td>Vascular\/structural: lymphatic support; anti-edema effect<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Niacinamide<\/strong> (2\u20133%)<\/td>\n              <td>Pigmentation : modulation du transfert des m\u00e9lanosomes<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Ac\u00e9tyl t\u00e9trapeptide-5<\/strong><\/td>\n              <td>Structurel : soutien lymphatique ; activit\u00e9 anti-\u0153d\u00e8me<\/td>\n            <\/tr>\n          <\/tbody>\n        <\/table>\n      <\/div>\n\n      <h2>Consid\u00e9rations de formulation pour la zone oculaire<\/h2>\n\n      <h3>Texture<\/h3>\n\n      <p>Les cr\u00e8mes et s\u00e9rums pour les yeux n\u00e9cessitent des ajustements de texture sp\u00e9cifiques par rapport aux formulations faciales standard :<\/p>\n      <ul>\n        <li><strong>\u00c9mulsion tr\u00e8s l\u00e9g\u00e8re<\/strong> ou <strong>gel-cr\u00e8me<\/strong> pour la zone sous les yeux \u2014 \u00e9viter les textures occlusives lourdes qui peuvent provoquer des milliums dans la peau fine du contour de l'\u0153il<\/li>\n        <li><strong>Faible teneur en huile<\/strong> (\u226415 % dans une \u00e9mulsion H\/E) \u2014 des fractions d'huile plus \u00e9lev\u00e9es augmentent le risque de milliums<\/li>\n        <li><strong>\u00c9mollients non com\u00e9dog\u00e8nes<\/strong> \u2014 dim\u00e9thicone, cyclopentasiloxane, esters l\u00e9gers (triglyc\u00e9ride caprylique\/caprique)<\/li>\n      <\/ul>\n\n      <h3>S\u00e9lection de grades pour les formulations oculaires<\/h3>\n\n      <div class=\"table-wrap\">\n        <table>\n          <thead>\n            <tr>\n              <th>Format<\/th>\n              <th>Grade recommand\u00e9<\/th>\n              <th>Notes<\/th>\n            <\/tr>\n          <\/thead>\n          <tbody>\n            <tr>\n              <td>S\u00e9rum oculaire \u00e0 base d'eau<\/td>\n              <td>Glabridin hydrosoluble (HP-\u03b2-CD) \u00e0 1\u20133 %<\/td>\n              <td>Dispersion aqueuse directe ; un co-solvant peut ne pas \u00eatre n\u00e9cessaire en fonction de la conception du syst\u00e8me<\/td>\n            <\/tr>\n            <tr>\n              <td>Cr\u00e8me oculaire l\u00e9g\u00e8re H\/E<\/td>\n              <td>40 % de poudre blanche (pr\u00e9dissoute dans le PG ou le BG au refroidissement)<\/td>\n              <td>La concentration en polyols peut favoriser la dissolution en fonction des conditions de formulation<\/td>\n            <\/tr>\n            <tr>\n              <td>Soin oculaire huile-s\u00e9rum<\/td>\n              <td>90 % de glabridine liposoluble<\/td>\n              <td>0,2 % dans la fraction huileuse ; con\u00e7u pour minimiser le risque de s\u00e9dimentation dans des conditions de formulation appropri\u00e9es<\/td>\n            <\/tr>\n          <\/tbody>\n        <\/table>\n      <\/div>\n\n      <h3>pH cible<\/h3>\n\n      <p>pH 4,5\u20135,5 \u2014 g\u00e9n\u00e9ralement compatible avec la plage de stabilit\u00e9 de la glabridine et le pH physiologique de la peau du contour de l'\u0153il. De mani\u00e8re critique, cette plage soutient \u00e9galement la fonction barri\u00e8re dans la peau fine et plus perm\u00e9able du contour de l'\u0153il, o\u00f9 un d\u00e9s\u00e9quilibre du pH peut affecter la tol\u00e9rance de mani\u00e8re plus notable.<\/p>\n\n      <p>Tamponner avec de l'acide citrique\/citrate de sodium ou de l'acide lactique\/lactate de sodium. L'acide lactique est un bon choix pour les produits destin\u00e9s au contour des yeux \u2014 il est naturellement pr\u00e9sent dans le NMF de la peau, soutient l'hydratation et est g\u00e9n\u00e9ralement bien tol\u00e9r\u00e9 \u00e0 faibles concentrations dans les formulations pour le contour des yeux.<\/p>\n\n      <h3>Consid\u00e9rations relatives aux conservateurs<\/h3>\n\n      <p>La peau fine et perm\u00e9able de la zone p\u00e9riorbitaire peut augmenter la sensibilit\u00e9 locale et le potentiel de p\u00e9n\u00e9tration des ingr\u00e9dients de la formulation. S\u00e9lectionner des conservateurs ayant un historique d'utilisation bien \u00e9tabli dans les formulations ophtalmiques ou pour le contour des yeux. Les parab\u00e8nes ont un long historique d'utilisation s\u00fbre dans les produits oculaires. Le ph\u00e9noxy\u00e9thanol aux concentrations typiques (\u22641 %) est largement accept\u00e9. Les conservateurs de la famille des isothiazolinones sont g\u00e9n\u00e9ralement \u00e9vit\u00e9s dans les formulations pour le contour des yeux en raison de pr\u00e9occupations li\u00e9es \u00e0 la sensibilisation.<\/p>\n\n      <h3>Conditionnement<\/h3>\n\n      <p>Pompe sans air ou compte-gouttes en verre avec un joint \u00e9tanche. Les formats de pots ouverts ne sont g\u00e9n\u00e9ralement pas pr\u00e9f\u00e9r\u00e9s pour les produits destin\u00e9s au contour des yeux \u2014 le contact r\u00e9p\u00e9t\u00e9 avec les doigts peut augmenter le risque de contamination, et les exigences du syst\u00e8me de conservation sont particuli\u00e8rement importantes pour les formulations p\u00e9riorbitaires en raison de la sensibilit\u00e9 accrue et de l'utilisation fr\u00e9quente pr\u00e8s de la zone oculaire.<\/p>\n\n      <h2>Formulation \u00e9claircissante pour le contour des yeux \u2014 Sch\u00e9ma structurel<\/h2>\n\n      <div class=\"table-wrap\">\n        <table>\n          <thead>\n            <tr>\n              <th>Phase<\/th>\n              <th>Ingr\u00e9dient<\/th>\n              <th>Cible 1 %<\/th>\n              <th>Fonction<\/th>\n            <\/tr>\n          <\/thead>\n          <tbody>\n            <tr>\n              <td>Phase aqueuse<\/td>\n              <td>Eau purifi\u00e9e<\/td>\n              <td>q.s.<\/td>\n              <td>Support<\/td>\n            <\/tr>\n            <tr>\n              <td>Phase aqueuse<\/td>\n              <td>Acide lactique \/ Lactate de sodium<\/td>\n              <td>Tampon<\/td>\n              <td>pH 4,8\u20135,2 avant les actifs<\/td>\n            <\/tr>\n            <tr>\n              <td>Phase aqueuse<\/td>\n              <td>EDTA disodique<\/td>\n              <td>0,05%<\/td>\n              <td>ch\u00e9lation des m\u00e9taux<\/td>\n            <\/tr>\n            <tr>\n              <td>Phase aqueuse<\/td>\n              <td>Niacinamide<\/td>\n              <td>2\u20133 %<\/td>\n              <td>Modulation du transfert des m\u00e9lanosomes<\/td>\n            <\/tr>\n            <tr>\n              <td>Phase aqueuse<\/td>\n              <td>Caf\u00e9ine<\/td>\n              <td>1\u20132 %<\/td>\n              <td>Composant vasculaire ; r\u00e9duction des poches<\/td>\n            <\/tr>\n            <tr>\n              <td>Phase aqueuse<\/td>\n              <td>Dipeptide-2<\/td>\n              <td>Selon la recommandation du fournisseur<\/td>\n              <td>Soutien lymphatique ; activit\u00e9 anti-\u0153d\u00e8me<\/td>\n            <\/tr>\n            <tr>\n              <td>Phase aqueuse<\/td>\n              <td>Ac\u00e9tyl t\u00e9trapeptide-5<\/td>\n              <td>Selon la recommandation du fournisseur<\/td>\n              <td>Soutien lymphatique ; activit\u00e9 anti-\u0153d\u00e8me<\/td>\n            <\/tr>\n            <tr>\n              <td>Phase aqueuse<\/td>\n              <td>Acide hyaluronique (faible poids mol\u00e9culaire)<\/td>\n              <td>0,1\u20130,5 %<\/td>\n              <td>Hydratation p\u00e9riorbitaire<\/td>\n            <\/tr>\n            <tr>\n              <td>Phase huileuse<\/td>\n              <td>Triglyc\u00e9ride caprylique\/caprique<\/td>\n              <td>5\u201310 %<\/td>\n              <td>\u00c9mollient l\u00e9ger et non com\u00e9dog\u00e8ne<\/td>\n            <\/tr>\n            <tr>\n              <td>Phase huileuse<\/td>\n              <td>Dim\u00e9thicone<\/td>\n              <td>1\u20133 %<\/td>\n              <td>Sensoriel ; non com\u00e9dog\u00e8ne<\/td>\n            <\/tr>\n            <tr>\n              <td>\u00c9mulsifiant<\/td>\n              <td>Syst\u00e8me \u00e9mulsifiant sans PEG<\/td>\n              <td>Selon les besoins<\/td>\n              <td>\u00c9mulsion H\/E l\u00e9g\u00e8re<\/td>\n            <\/tr>\n            <tr>\n              <td>Refroidissement<\/td>\n              <td><strong>Glabridine<\/strong> (10 % hydrosoluble ou 40 % pr\u00e9dissous)<\/td>\n              <td>0,1\u20130,2 % d'actif<\/td>\n              <td>Ancre \u00e9claircissante principale<\/td>\n            <\/tr>\n            <tr>\n              <td>Refroidissement<\/td>\n              <td>Tocoph\u00e9rols mixtes<\/td>\n              <td>0,2%<\/td>\n              <td>Antioxydant<\/td>\n            <\/tr>\n            <tr>\n              <td>Refroidissement<\/td>\n              <td>Preservative<\/td>\n              <td>Selon les besoins<\/td>\n              <td>Syst\u00e8me adapt\u00e9 au contour de l'\u0153il<\/td>\n            <\/tr>\n            <tr>\n              <td>Final<\/td>\n              <td>V\u00e9rification du pH<\/td>\n              <td>Cible 4,5\u20135,5<\/td>\n              <td>Apr\u00e8s tous les ajouts<\/td>\n            <\/tr>\n          <\/tbody>\n        <\/table>\n      <\/div>\n\n      <div class=\"callout\">\n        <p>Chaque lot est exp\u00e9di\u00e9 avec COA, TDS et SDS\/MSDS. Tests suppl\u00e9mentaires disponibles sur demande.<\/p>\n      <\/div>\n\n      <!-- Related -->\n      <div class=\"related-section\">\n        <h2>Ressources connexes<\/h2>\n        <div class=\"related-links\">\n          <a class=\"related-link\" href=\"https:\/\/glabridinchina.com\/fr\/glabridin\/\">\n            <span>Guide de la Glabridine pour la Formulation Cosm\u00e9tique \u2014 R\u00e9f\u00e9rence Technique Compl\u00e8te<br>\n            <small style=\"color:var(--color-text-muted);font-weight:400\">Matrice compl\u00e8te des m\u00e9canismes, des grades et des conseils d'application<\/small><\/span>\n            <span class=\"related-link-arrow\">\u2192<\/span>\n          <\/a>\n          <a class=\"related-link\" href=\"https:\/\/glabridinchina.com\/fr\/can-glabridin-be-used-in-sensitive-skin-products\/\">\n            <span>Le glabridin peut-il \u00eatre utilis\u00e9 dans les produits pour peaux sensibles ?<br>\n            <small style=\"color:var(--color-text-muted);font-weight:400\">Profil de s\u00e9curit\u00e9 et m\u00e9canisme anti-inflammatoire<\/small><\/span>\n            <span class=\"related-link-arrow\">\u2192<\/span>\n          <\/a>\n          <a class=\"related-link\" href=\"https:\/\/glabridinchina.com\/fr\/glabridin-niacinamide-complementary-mechanisms-in-multilevel-brightening\/\">\n            <span>Glabridine et Niacinamide : M\u00e9canismes Compl\u00e9mentaires dans le Blanchiment Multicouche<br>\n            <small style=\"color:var(--color-text-muted);font-weight:400\">Couverture \u00e9claircissante en amont et en aval<\/small><\/span>\n            <span class=\"related-link-arrow\">\u2192<\/span>\n          <\/a>\n          <a class=\"related-link\" href=\"https:\/\/glabridinchina.com\/fr\/what-ph-range-does-glabridin-require-in-cosmetic-formulations\uff1f\/\">\n            <span>Quelle plage de pH la glabridine n\u00e9cessite-t-elle dans les formulations cosm\u00e9tiques ?<br>\n            <small style=\"color:var(--color-text-muted);font-weight:400\">Gestion du pH pour les formats de peau sensible<\/small><\/span>\n            <span class=\"related-link-arrow\">\u2192<\/span>\n          <\/a>\n        <\/div>\n      <\/div>\n\n      <!-- CTA -->\n      <div class=\"cta-box\">\n        <div class=\"cta-box-text\">\n          <strong>Demander des \u00e9chantillons, un COA ou une consultation technique<\/strong>\n          glabridinchina.com \u00b7 jelly@huataibio.com \u00b7 +86 17868678161\n        <\/div>\n        <a class=\"cta-btn\" href=\"https:\/\/glabridinchina.com\/fr\/nous-contacter\/\">Contactez-nous \u2192<\/a>\n      <\/div>\n\n      <!-- References -->\n      <div class=\"references\">\n        <h2>R\u00e9f\u00e9rences<\/h2>\n        <ol>\n          <li>Yokota T, Nishio H, Kubota Y, Mizoguchi M. L'effet inhibiteur de la glabridine extraite de la r\u00e9glisse sur la m\u00e9lanogen\u00e8se et l'inflammation. <em>Pigment Cell Research<\/em>, 11(6), 355\u2013361, 1998. DOI: 10.1111\/j.1600-0749.1998.tb00494.x.<\/li>\n          <li>Hakozaki T, Minwalla L, Zhuang J, et al. L'effet de la niacinamide sur la r\u00e9duction de la pigmentation cutan\u00e9e et la suppression du transfert des m\u00e9lanosomes. <em>Dermatologie britannique<\/em>, 147(1), 20\u201331, 2002. DOI : 10.1046\/j.1365-2133.2002.04834.x.<\/li>\n          <li>Guangdong Weipu Testing Technology Co., Ltd. (CMA No. 202119135666). Rapport n\u00b0 GZA01-23080632-JC-01. \u00c9tude d'efficacit\u00e9 \u00e9claircissante sur la peau humaine + test de patch, 0.03% Glabridine. Command\u00e9 par Huatai Bio-Fine Chemical.<\/li>\n        <\/ol>\n      <\/div>\n\n      <div class=\"article-footer\">\n        <p>Pour les formulateurs de cosm\u00e9tiques professionnels et les publics de R&amp;D. Ne constitue pas un avis r\u00e9glementaire.<br>\n        Publi\u00e9 en 2026 \u2014 Huatai Bio-Fine Chemical, Xi'an, Shaanxi, Chine.<\/p>\n      <\/div>\n\n    <\/article>\n  <\/div>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Application Glabridine Zone Oculaire Cernes Les cernes figurent parmi les pr\u00e9occupations esth\u00e9tiques les plus courantes en mati\u00e8re de soins de la peau \u2014 et parmi les plus fr\u00e9quemment mal formul\u00e9es. Les\u2026<\/p>","protected":false},"author":8,"featured_media":5795,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[411],"tags":[],"class_list":["post-14275","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-application-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.8 (Yoast SEO v24.2) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Eye Area Brightening: Addressing Dark Circles with Glabridin | Huatai Bio-Fine Chemical<\/title>\n<meta name=\"description\" content=\"A technical guide to formulating dark circle treatments using glabridin \u2014 covering the three distinct causes of periorbital darkness, active system design, grade selection, and formulation considerations for the periorbital zone. From Huatai, manufacturer of high-purity glabridin since 2008.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/glabridinchina.com\/fr\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eye Area Brightening: Addressing Dark Circles with Glabridin\" \/>\n<meta property=\"og:description\" content=\"A technical guide to formulating dark circle treatments using glabridin \u2014 covering the three distinct causes of periorbital darkness, active system design, grade selection, and formulation considerations for the periorbital zone. From Huatai, manufacturer of high-purity glabridin since 2008.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/glabridinchina.com\/fr\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\" \/>\n<meta property=\"og:site_name\" content=\"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-25T09:21:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-25T09:25:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1242\" \/>\n\t<meta property=\"og:image:height\" content=\"699\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Huatai\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Huatai\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\"},\"author\":{\"name\":\"Huatai\",\"@id\":\"https:\/\/glabridinchina.com\/#\/schema\/person\/1fc9183390cde309170faf98dbabcaab\"},\"headline\":\"Eye Area Brightening: Addressing Dark Circles with Glabridin\",\"datePublished\":\"2026-06-25T09:21:10+00:00\",\"dateModified\":\"2026-06-25T09:25:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\"},\"wordCount\":1514,\"publisher\":{\"@id\":\"https:\/\/glabridinchina.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg\",\"articleSection\":[\"Application Guides\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\",\"url\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\",\"name\":\"Eye Area Brightening: Addressing Dark Circles with Glabridin | Huatai Bio-Fine Chemical\",\"isPartOf\":{\"@id\":\"https:\/\/glabridinchina.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg\",\"datePublished\":\"2026-06-25T09:21:10+00:00\",\"dateModified\":\"2026-06-25T09:25:43+00:00\",\"description\":\"A technical guide to formulating dark circle treatments using glabridin \u2014 covering the three distinct causes of periorbital darkness, active system design, grade selection, and formulation considerations for the periorbital zone. From Huatai, manufacturer of high-purity glabridin since 2008.\",\"breadcrumb\":{\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage\",\"url\":\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg\",\"contentUrl\":\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg\",\"width\":1242,\"height\":699,\"caption\":\"Glabridin ingredient\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/glabridinchina.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eye Area Brightening: Addressing Dark Circles with Glabridin\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/glabridinchina.com\/#website\",\"url\":\"https:\/\/glabridinchina.com\/\",\"name\":\"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.\",\"description\":\"Huatai Bio-Fine Chemicals: ISO-certified manufacturer of high-purity skincare ingredients like Glabridin and Tranexamic Acid. Offering flexible supply with full documentation for brands &amp; OEMs worldwide.\",\"publisher\":{\"@id\":\"https:\/\/glabridinchina.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/glabridinchina.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/glabridinchina.com\/#organization\",\"name\":\"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.\",\"url\":\"https:\/\/glabridinchina.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/glabridinchina.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2024\/10\/\u516c\u53f8LOGO.webp\",\"contentUrl\":\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2024\/10\/\u516c\u53f8LOGO.webp\",\"width\":1278,\"height\":783,\"caption\":\"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.\"},\"image\":{\"@id\":\"https:\/\/glabridinchina.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/glabridinchina.com\/#\/schema\/person\/1fc9183390cde309170faf98dbabcaab\",\"name\":\"Huatai\",\"url\":\"https:\/\/glabridinchina.com\/fr\/author\/huatai\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Eye Area Brightening: Addressing Dark Circles with Glabridin | Huatai Bio-Fine Chemical","description":"A technical guide to formulating dark circle treatments using glabridin \u2014 covering the three distinct causes of periorbital darkness, active system design, grade selection, and formulation considerations for the periorbital zone. From Huatai, manufacturer of high-purity glabridin since 2008.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/glabridinchina.com\/fr\/eye-area-brightening-addressing-dark-circles-with-glabridin\/","og_locale":"fr_FR","og_type":"article","og_title":"Eye Area Brightening: Addressing Dark Circles with Glabridin","og_description":"A technical guide to formulating dark circle treatments using glabridin \u2014 covering the three distinct causes of periorbital darkness, active system design, grade selection, and formulation considerations for the periorbital zone. From Huatai, manufacturer of high-purity glabridin since 2008.","og_url":"https:\/\/glabridinchina.com\/fr\/eye-area-brightening-addressing-dark-circles-with-glabridin\/","og_site_name":"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.","article_published_time":"2026-06-25T09:21:10+00:00","article_modified_time":"2026-06-25T09:25:43+00:00","og_image":[{"width":1242,"height":699,"url":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg","type":"image\/jpeg"}],"author":"Huatai","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Huatai"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#article","isPartOf":{"@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/"},"author":{"name":"Huatai","@id":"https:\/\/glabridinchina.com\/#\/schema\/person\/1fc9183390cde309170faf98dbabcaab"},"headline":"Eye Area Brightening: Addressing Dark Circles with Glabridin","datePublished":"2026-06-25T09:21:10+00:00","dateModified":"2026-06-25T09:25:43+00:00","mainEntityOfPage":{"@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/"},"wordCount":1514,"publisher":{"@id":"https:\/\/glabridinchina.com\/#organization"},"image":{"@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage"},"thumbnailUrl":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg","articleSection":["Application Guides"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/","url":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/","name":"Eye Area Brightening: Addressing Dark Circles with Glabridin | Huatai Bio-Fine Chemical","isPartOf":{"@id":"https:\/\/glabridinchina.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage"},"image":{"@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage"},"thumbnailUrl":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg","datePublished":"2026-06-25T09:21:10+00:00","dateModified":"2026-06-25T09:25:43+00:00","description":"A technical guide to formulating dark circle treatments using glabridin \u2014 covering the three distinct causes of periorbital darkness, active system design, grade selection, and formulation considerations for the periorbital zone. From Huatai, manufacturer of high-purity glabridin since 2008.","breadcrumb":{"@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage","url":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg","contentUrl":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg","width":1242,"height":699,"caption":"Glabridin ingredient"},{"@type":"BreadcrumbList","@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/glabridinchina.com\/"},{"@type":"ListItem","position":2,"name":"Eye Area Brightening: Addressing Dark Circles with Glabridin"}]},{"@type":"WebSite","@id":"https:\/\/glabridinchina.com\/#website","url":"https:\/\/glabridinchina.com\/","name":"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.","description":"Huatai Bio-Fine Chemicals: ISO-certified manufacturer of high-purity skincare ingredients like Glabridin and Tranexamic Acid. Offering flexible supply with full documentation for brands &amp; OEMs worldwide.","publisher":{"@id":"https:\/\/glabridinchina.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/glabridinchina.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/glabridinchina.com\/#organization","name":"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.","url":"https:\/\/glabridinchina.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/glabridinchina.com\/#\/schema\/logo\/image\/","url":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2024\/10\/\u516c\u53f8LOGO.webp","contentUrl":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2024\/10\/\u516c\u53f8LOGO.webp","width":1278,"height":783,"caption":"Shaanxi Huatai Bio-Fine Chemical Co., Ltd."},"image":{"@id":"https:\/\/glabridinchina.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/glabridinchina.com\/#\/schema\/person\/1fc9183390cde309170faf98dbabcaab","name":"Huatai","url":"https:\/\/glabridinchina.com\/fr\/author\/huatai\/"}]}},"_links":{"self":[{"href":"https:\/\/glabridinchina.com\/fr\/wp-json\/wp\/v2\/posts\/14275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/glabridinchina.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/glabridinchina.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/glabridinchina.com\/fr\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/glabridinchina.com\/fr\/wp-json\/wp\/v2\/comments?post=14275"}],"version-history":[{"count":4,"href":"https:\/\/glabridinchina.com\/fr\/wp-json\/wp\/v2\/posts\/14275\/revisions"}],"predecessor-version":[{"id":14279,"href":"https:\/\/glabridinchina.com\/fr\/wp-json\/wp\/v2\/posts\/14275\/revisions\/14279"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/glabridinchina.com\/fr\/wp-json\/wp\/v2\/media\/5795"}],"wp:attachment":[{"href":"https:\/\/glabridinchina.com\/fr\/wp-json\/wp\/v2\/media?parent=14275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/glabridinchina.com\/fr\/wp-json\/wp\/v2\/categories?post=14275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/glabridinchina.com\/fr\/wp-json\/wp\/v2\/tags?post=14275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}